Retinoblastoma
Retinoblastoma is a cancer that starts in the retina, It is the most common type of eye cancer in children. The obvious sign of retinoblastoma is an unusual appearance of the retina as viewed through the pupil, the medical term for which is leukocoria, also known as amaurotic cat's eye reflex. Other signs and symptoms include deterioration of vision, a red and irritated eye with glaucoma, and faltering development or delayed development. Some children with retinoblastoma can develop a cross-eyed. Retinoblastoma presents with advanced disease in emerging countries and eye enlargement is a common finding.
Related Conference of Retinoblastoma
April 13-14, 2026
23rd International Conference on Breast Pathology and Cancer Diagnosis
Tokyo, Japan
Retinoblastoma Conference Speakers
Recommended Sessions
Related Journals
Are you interested in
- Abdominal Oncology Imaging - RADIOLOGY AND ONCOLOGY 2026 (France)
- Advanced MRI Techniques in Oncology - RADIOLOGY AND ONCOLOGY 2026 (France)
- Advancement in the Field of Cancer - CANCER THERAPY MEETING 2026 (France)
- Advances in Brachytherapy Techniques - Euro Cancer 2026 (France)
- Advances in Breast Cancer Diagnosis - Breast Cancer Summit 2026 (France)
- Advances in Immuno-Oncology - CANCER THERAPY MEETING 2026 (France)
- Advances in Immuno-Oncology and CAR-T Cell Therapies - CANCER2026 (France)
- Advances in Pediatric Oncology Imaging & Therapy - Cancer Meeting Summit 2026 (France)
- Advances in Stereotactic Body Radiation Therapy (SBRT) - Euro Cancer 2026 (France)
- Advances in Supportive Care and Symptom Management - CANCER THERAPY MEETING 2026 (France)
- AI and Machine Learning in Cancer Diagnosis - Cancer Meeting Summit 2026 (France)
- AI and Machine Learning in Radiation Oncology - Euro Cancer 2026 (France)
- AI-Driven Treatment Planning and Workflow Optimization - Cancer Meeting Summit 2026 (France)
- Alternative Treatments and Therapeutics - Cancer Science 2026 (UAE)
- Artificial Intelligence & Big Data in Breast Oncology - Breast Cancer Summit 2026 (France)
- Artificial Intelligence and Big Data in Cancer Research - CANCER THERAPY MEETING 2026 (France)
- Artificial Intelligence and Digital Innovations in Oncology - CANCER2026 (France)
- Artificial Intelligence in Breast Imaging - Breast Cancer-2026 (Italy)
- Artificial Intelligence in Cancer Radiology - RADIOLOGY AND ONCOLOGY 2026 (France)
- Biological Basis of Cancer Stem Cells - Cancer Stem Cells 2026 (Italy)
- Biomarker Discovery and Molecular Diagnostics in Cancer - CANCER2026 (France)
- Biomarkers for Radiation Response Prediction - Euro Cancer 2026 (France)
- Breakthroughs in Precision Cancer Treatments - Cancer Meeting Summit 2026 (France)
- Breast Cancer - Cancer Science 2026 (UAE)
- Breast Cancer and Cell Biology - Breast Cancer 2026 (UAE)
- Breast Cancer and Immunology - Breast Cancer 2026 (UAE)
- Breast Cancer and Pregnancy - Breast Cancer Summit 2026 (France)
- Breast Cancer Awareness - Breast Cancer 2026 (UAE)
- Breast Cancer Biomarkers and Prognosis - Breast Cancer-2026 (Italy)
- Breast Cancer Clinical Trials - Breast Cancer 2026 (UAE)
- Breast Cancer Detection, Prevention, and Diagnosis - Breast Cancer 2026 (UAE)
- Breast Cancer Imaging and Radiology - Breast Cancer Summit 2026 (France)
- Breast Cancer in Men - Breast Cancer Summit 2026 (France)
- Breast Cancer in Men - Breast Cancer-2026 (Italy)
- Breast Cancer in Young Women - Breast Cancer Summit 2026 (France)
- Breast Cancer Management - Breast Cancer 2026 (UAE)
- Breast Cancer Nursing - Breast Cancer 2026 (UAE)
- Breast Cancer Prevention and Lifestyle - Breast Cancer Summit 2026 (France)
- Breast Cancer Prevention Strategies - Breast Cancer-2026 (Italy)
- Breast Cancer Risk - Breast Cancer 2026 (UAE)
- Breast Cancer Staging - Breast Cancer 2026 (UAE)
- Breast Cancer Surgery - Breast Cancer 2026 (UAE)
- Breast Cancer Survivorship and Quality of Life - Breast Cancer-2026 (Italy)
- Breast Cancer Types and Etiology - Breast Cancer 2026 (UAE)
- Breast Cancer, Cancer Therapies And Breast Cancer Treatment - Women Oncology-2026 (USA)
- Breast Reconstruction and Cosmetic Outcomes - Breast Cancer Summit 2026 (France)
- Breast Reconstruction and Cosmetic Surgery - Breast Cancer-2026 (Italy)
- Cancer & Biopsies - Cancer diagnostics 2026 (USA)
- Cancer Biology - Women Oncology-2026 (USA)
- Cancer Biomarker - Cancer diagnostics 2026 (USA)
- Cancer Biomarkers - Women Oncology-2026 (USA)
- Cancer Care in the Era of Digital Health - CANCER THERAPY MEETING 2026 (France)
- Cancer Cell Biology & Genetics - Cancer Meeting Summit 2026 (France)
- Cancer Clinical Trails - Cancer diagnostics 2026 (USA)
- Cancer Control and Prevention - Cancer Science 2026 (UAE)
- Cancer Development - Women Oncology-2026 (USA)
- Cancer Diagnostics Market - Cancer diagnostics 2026 (USA)
- Cancer Diagnostics Tools, Technologies and Procedures - Cancer diagnostics 2026 (USA)
- Cancer Drugs - Women Oncology-2026 (USA)
- Cancer Early Detection, Diagnosis and Prognosis - Cancer Meeting Summit 2026 (France)
- Cancer Epidemiology and Prevention - CANCER THERAPY MEETING 2026 (France)
- Cancer Epidemiology, Screening, Diagnosis & Prognosis - Women Oncology-2026 (USA)
- Cancer Epigenetics - Cancer Science 2026 (UAE)
- Cancer Genomics & Metabolomics - CANCER THERAPY MEETING 2026 (France)
- Cancer Genomics and Epigenetics - Cancer diagnostics 2026 (USA)
- Cancer Health Disparities - Women Oncology-2026 (USA)
- Cancer Immunology - CANCER THERAPY MEETING 2026 (France)
- Cancer Immunotherapy and Types - Cancer diagnostics 2026 (USA)
- Cancer Metabolism and Therapeutic Interventions - CANCER THERAPY MEETING 2026 (France)
- Cancer Metastasis - Cancer Science 2026 (UAE)
- Cancer Nanotechnology - Cancer diagnostics 2026 (USA)
- Cancer Prevention, Screening, and Public Health Strategies - CANCER2026 (France)
- Cancer Preventive Vaccines: Oncolytic Therapy & Others - Women Oncology-2026 (USA)
- Cancer Radiology - Cancer diagnostics 2026 (USA)
- Cancer Risk Factors - Women Oncology-2026 (USA)
- Cancer Science - Women Oncology-2026 (USA)
- Cancer Science - Cancer Science 2026 (UAE)
- Cancer Screening & Chemotherapy - Cancer Meeting Summit 2026 (France)
- Cancer Stem Cells - Women Oncology-2026 (USA)
- Cancer Stem Cells: Understanding and Targeting - CANCER THERAPY MEETING 2026 (France)
- Cancer Survivorship and Quality of Life - CANCER THERAPY MEETING 2026 (France)
- Cancer Treatment - Women Oncology-2026 (USA)
- Cancer Treatment and Therapies - Cancer diagnostics 2026 (USA)
- Cancer vaccines - Women Oncology-2026 (USA)
- Cancer Vaccines - CANCER THERAPY MEETING 2026 (France)
- Cancer Vaccines - Cancer Meeting Summit 2026 (France)
- Cancer Vaccines and Therapeutics - Cancer diagnostics 2026 (USA)
- Cancers Biomarkers - Cancer Science 2026 (UAE)
- Cancers Pharmacology - Cancer Science 2026 (UAE)
- Cardio Oncology - Women Oncology-2026 (USA)
- Case Studies - Breast Cancer 2026 (UAE)
- Cell Cycle Regulation in Cancer Stem Cells - Cancer Stem Cells 2026 (Italy)
- Cell-Based Therapy - CANCER THERAPY MEETING 2026 (France)
- Cellular Plasticity in Cancer Stem Cells - Cancer Stem Cells 2026 (Italy)
- Cellular Polarity and Asymmetric Division - Cancer Stem Cells 2026 (Italy)
- Cellular Stress Response in Cancer Stem Cells - Cancer Stem Cells 2026 (Italy)
- Chromatin Organization and Cellular Identity - Cancer Stem Cells 2026 (Italy)
- Circulating Tumor Cell (CTC) - Women Oncology-2026 (USA)
- Clinical Cancer research - Cancer diagnostics 2026 (USA)
- Clinical Trials and New Drug Development - CANCER THERAPY MEETING 2026 (France)
- Clinical Trials in Advanced Radiation Therapy - Euro Cancer 2026 (France)
- Combination Therapies in Metastatic Cancer Management - Euro Cancer 2026 (France)
- CyberKnife and Robotic Radiosurgery Developments - Euro Cancer 2026 (France)
- Diet and Lifestyle Effects on Breast Cancer - Breast Cancer 2026 (UAE)
- Digital Oncology, Big Data, and Treatment Optimization - Euro Cancer 2026 (France)
- DNA Damage Response Mechanisms - Cancer Stem Cells 2026 (Italy)
- DNA Damage, Mutation and Cancer - Cancer Meeting Summit 2026 (France)
- Drug Resistance and Overcoming Challenges - CANCER THERAPY MEETING 2026 (France)
- Early Cancer Detection and Liquid Biopsy Technologies - CANCER2026 (France)
- Early Detection and Biomarker-Driven Care - Cancer Meeting Summit 2026 (France)
- Emerging Radiopharmaceuticals and Molecular Imaging - Cancer Meeting Summit 2026 (France)
- Emerging Therapies and Future Directions in Oncology - CANCER2026 (France)
- Epidemiology of Breast Cancer and Risk Factors - Breast Cancer 2026 (UAE)
- Epigenetic Regulation in Cancer Stem Cells - Cancer Stem Cells 2026 (Italy)
- Epigenetics and Gene Editing in Cancer Therapy - CANCER2026 (France)
- Ethical and Regulatory Issues in Cancer Research - CANCER THERAPY MEETING 2026 (France)
- Evolutionary Dynamics of Cancer Stem Cell Populations - Cancer Stem Cells 2026 (Italy)
- Future Directions in Cancer Therapy and Research - CANCER THERAPY MEETING 2026 (France)
- Future Directions in Oncology Imaging - RADIOLOGY AND ONCOLOGY 2026 (France)
- Future Trends in Oncology Technology and Global Impact - Euro Cancer 2026 (France)
- Genetic Instability and Cancer Stem Cells - Cancer Stem Cells 2026 (Italy)
- Genetic Mutations Of Cancer - Women Oncology-2026 (USA)
- Genetic Predisposition and BRCA Mutations - Breast Cancer Summit 2026 (France)
- Genomic Profiling for Personalized Cancer Care - Cancer Meeting Summit 2026 (France)
- Global Access to Radiation Therapy and Health Equity - Euro Cancer 2026 (France)
- Global Innovations in Cancer Care Delivery & Accessibility - Cancer Meeting Summit 2026 (France)
- Global Oncology Trends and Future Perspectives - CANCER2026 (France)
- Gynecologic Oncology - Women Oncology-2026 (USA)
- Health Economics, Access, and Policy in Oncology - CANCER2026 (France)
- Hematology- Oncology - Cancer Science 2026 (UAE)
- HER2-Positive Breast Cancer - Breast Cancer Summit 2026 (France)
- HER2-Positive Breast Cancer Advances - Breast Cancer-2026 (Italy)
- Hormone Receptor-Positive Breast Cancer - Breast Cancer Summit 2026 (France)
- Hormone Receptor-Positive Subtypes - Breast Cancer-2026 (Italy)
- Hybrid Imaging Technologies - RADIOLOGY AND ONCOLOGY 2026 (France)
- Hypofractionation and Ultra-Short Radiation Protocols - Euro Cancer 2026 (France)
- Hypoxia and Cancer Stem Cell Biology - Cancer Stem Cells 2026 (Italy)
- Image-Guided and MRI-Guided Radiotherapy - Euro Cancer 2026 (France)
- Image-Guided Interventional Oncology - RADIOLOGY AND ONCOLOGY 2026 (France)
- Imaging-Guided Radiation Oncology - RADIOLOGY AND ONCOLOGY 2026 (France)
- Immunotherapy and Breast Cancer - Breast Cancer-2026 (Italy)
- Immunotherapy and Next-Generation Cancer Vaccines - CANCER2026 (France)
- Immunotherapy and Novel Therapeutic Approaches - Cancer Meeting Summit 2026 (France)
- Immunotherapy and Radiation Synergy Strategies - Euro Cancer 2026 (France)
- Immunotherapy in Breast Cancer - Breast Cancer-2026 (Italy)
- Improved Survivorship Care and Quality-of-Life Strategies - Cancer Meeting Summit 2026 (France)
- Industry Innovations in Radiation Delivery Systems - Euro Cancer 2026 (France)
- Inflammation Driven Regulation of Cancer Stem Cells - Cancer Stem Cells 2026 (Italy)
- Inflammatory Breast Cancer - Breast Cancer 2026 (UAE)
- Innovations in Breast Cancer Treatment - Breast Cancer Summit 2026 (France)
- Innovations in Cancer Data and Informatics - CANCER THERAPY MEETING 2026 (France)
- Innovative Approaches in Cancer Radiology - CANCER THERAPY MEETING 2026 (France)
- Integrating Multidisciplinary Strategies in Cancer Care - Cancer Meeting Summit 2026 (France)
- Integration of Patient-Reported Outcomes in Cancer therapy - CANCER THERAPY MEETING 2026 (France)
- Integrative Oncology for Holistic Patient Support - Cancer Meeting Summit 2026 (France)
- Intercellular Communication Within Tumors - Cancer Stem Cells 2026 (Italy)
- Liquid Biopsies and Non-Invasive Diagnostic Tools - Cancer Meeting Summit 2026 (France)
- Liquid Biopsy and Early Cancer Detection - CANCER THERAPY MEETING 2026 (France)
- Liquid Biopsy and Non-Invasive Diagnostics - Breast Cancer-2026 (Italy)
- Male Breast Cancer Research - Breast Cancer 2026 (UAE)
- Mammography - Breast Cancer 2026 (UAE)
- Metabolic Characteristics of Cancer Stem Cells - Cancer Stem Cells 2026 (Italy)
- Metastatic Breast Cancer Management - Breast Cancer-2026 (Italy)
- Migration and Invasive Properties of Cancer Stem Cells - Cancer Stem Cells 2026 (Italy)
- Minimally Invasive Image-Guided Interventions - Cancer Meeting Summit 2026 (France)
- Molecular Diagnostics and Biomarkers in Cancer - CANCER THERAPY MEETING 2026 (France)
- Molecular Imaging and Functional Oncology - RADIOLOGY AND ONCOLOGY 2026 (France)
- Multidisciplinary Approaches and Integrated Cancer Care - CANCER2026 (France)
- Musculoskeletal Oncology Imaging - RADIOLOGY AND ONCOLOGY 2026 (France)
- Nanotechnology and Drug Delivery Innovations in Cancer Therapy - CANCER2026 (France)
- Nanotechnology in Cancer Diagnosis and Treatment - CANCER THERAPY MEETING 2026 (France)
- Nanotechnology In Cancer Treatment - Women Oncology-2026 (USA)
- Neoadjuvant and Adjuvant Therapies - Breast Cancer-2026 (Italy)
- Neonatal & Pediatric Oncology - Cancer Meeting Summit 2026 (France)
- Neonatal And Pediatric Oncology - Women Oncology-2026 (USA)
- Neuro-Oncology Imaging - RADIOLOGY AND ONCOLOGY 2026 (France)
- Next-Generation Imaging & Radiology Techniques - Cancer Meeting Summit 2026 (France)
- Oncogenomics - Cancer Science 2026 (UAE)
- Oncology Artificial Intelligence for Drug Discovery and Clinical Decision Support - CANCER2026 (France)
- Oncology Clinical Trials and Translational Research - CANCER2026 (France)
- Oncology Nursing - Women Oncology-2026 (USA)
- Oncology Nursing and Care - Cancer Science 2026 (UAE)
- Oncology Nursing: Advancements in Patient Care - CANCER THERAPY MEETING 2026 (France)
- Oncology Radiology, Nanotechnology - Cancer Meeting Summit 2026 (France)
- Oncology Research - Women Oncology-2026 (USA)
- Organ Specific Cancer - Women Oncology-2026 (USA)
- Organic Specific Cancer - Cancer Science 2026 (UAE)
- Pediatric Cancer Research and Therapeutics - CANCER THERAPY MEETING 2026 (France)
- Pediatric Oncology Imaging - RADIOLOGY AND ONCOLOGY 2026 (France)
- Pediatric Radiation Oncology: Precision and Safety - Euro Cancer 2026 (France)
- Personalized Medicine & Targeted Therapies - Cancer Meeting Summit 2026 (France)
- PET Imaging and Metabolic Oncology - RADIOLOGY AND ONCOLOGY 2026 (France)
- Phases And Types Of Clinical Trails - Women Oncology-2026 (USA)
- Precision Imaging for Early Cancer Identification - RADIOLOGY AND ONCOLOGY 2026 (France)
- Precision Medicine And Immuno-Oncology - Women Oncology-2026 (USA)
- Precision Oncology and Personalized Cancer Therapy - CANCER2026 (France)
- Precision Radiotherapy and Adaptive Treatment Planning - Euro Cancer 2026 (France)
- Predictive Cancer Biomarkers - Cancer diagnostics 2026 (USA)
- Proton Therapy and Particle Beam Innovations - Euro Cancer 2026 (France)
- Psychosocial Aspects of Breast Cancer - Breast Cancer-2026 (Italy)
- Psychosocial Support and Survivorship - Breast Cancer Summit 2026 (France)
- Psychotherapy and Cancer - CANCER THERAPY MEETING 2026 (France)
- Pulmonary Oncology - Women Oncology-2026 (USA)
- Quiescence and Dormancy in Cancer Stem Cells - Cancer Stem Cells 2026 (Italy)
- Radiation Oncology - Women Oncology-2026 (USA)
- Radiation Oncology Advances & Safety Innovations - Cancer Meeting Summit 2026 (France)
- Radiation Oncology in Breast Cancer - Breast Cancer-2026 (Italy)
- Radiation Oncology in Low- and Middle-Income Countries - Euro Cancer 2026 (France)
- Radiation Oncology: Innovations and Techniques - CANCER THERAPY MEETING 2026 (France)
- Radiation Therapy in Breast Cancer - Breast Cancer Summit 2026 (France)
- Radiation-Induced Toxicity and Mitigation Strategies - Euro Cancer 2026 (France)
- Radiogenomics and Personalized Cancer Treatment - Euro Cancer 2026 (France)
- Radiologic Mapping of Tumor Microenvironments - RADIOLOGY AND ONCOLOGY 2026 (France)
- Radiology - Breast Cancer 2026 (UAE)
- Radiology in Breast Oncology - RADIOLOGY AND ONCOLOGY 2026 (France)
- Radiology in Cancer Survivorship - RADIOLOGY AND ONCOLOGY 2026 (France)
- Radiology in Immuno-Oncology - RADIOLOGY AND ONCOLOGY 2026 (France)
- Radiology in Surgical Oncology Planning - RADIOLOGY AND ONCOLOGY 2026 (France)
- Radiomics and Quantitative Image Analysis - RADIOLOGY AND ONCOLOGY 2026 (France)
- Radiopharmaceuticals and Molecular Targeted Radiation - Euro Cancer 2026 (France)
- Radiotherapy Innovations and Precision Surgical Oncology - CANCER2026 (France)
- Re-Irradiation Strategies and Complex Case Management - Euro Cancer 2026 (France)
- Real-Time Tumor Monitoring and Adaptive Therapies - Cancer Meeting Summit 2026 (France)
- Recent Diagnostics Technologies - Cancer diagnostics 2026 (USA)
- Role of Microbiome in Cancer - CANCER THERAPY MEETING 2026 (France)
- Role of the Tumor Microenvironment in Cancer Stem Cell Maintenance - Cancer Stem Cells 2026 (Italy)
- Self Renewal and Differentiation Mechanisms - Cancer Stem Cells 2026 (Italy)
- Skin Cancer - Cancer Science 2026 (UAE)
- Stemness Gene Networks in Cancer - Cancer Stem Cells 2026 (Italy)
- Supportive Care, Palliative Oncology, and Patient-Centric Approaches - CANCER2026 (France)
- Surgical Innovations in Breast Cancer - Breast Cancer-2026 (Italy)
- Surgical Oncology in Breast Cancer - Breast Cancer Summit 2026 (France)
- Survivorship, Rehabilitation, and Long-Term Care in Oncology - CANCER2026 (France)
- Targeted Therapies Combined with Radiation - Euro Cancer 2026 (France)
- Targeted Therapy and Drug Development - Breast Cancer-2026 (Italy)
- Targeted Therapy and Molecular Oncology Advances - CANCER2026 (France)
- Targeted Therapy and Precision Medicine - CANCER THERAPY MEETING 2026 (France)
- Tele-Oncology and Digital Health in Cancer Care - CANCER2026 (France)
- Theranostics: Combined Imaging and Treatment Approaches - Cancer Meeting Summit 2026 (France)
- Thoracic Oncology Imaging - RADIOLOGY AND ONCOLOGY 2026 (France)
- Translational Research for Improved Patient Outcomes - Cancer Meeting Summit 2026 (France)
- Translational Research in Radiation Oncology - Euro Cancer 2026 (France)
- Triple-Negative Breast Cancer (TNBC) - Breast Cancer Summit 2026 (France)
- Triple-Negative Breast Cancer Research - Breast Cancer-2026 (Italy)
- Tumor Biology - Cancer Science 2026 (UAE)
- Tumor Cellular Heterogeneity and Stem Cell Hierarchy - Cancer Stem Cells 2026 (Italy)
- Tumor Microenvironment and Metastasis - CANCER THERAPY MEETING 2026 (France)
- Tumor Microenvironment and Radiosensitivity - Euro Cancer 2026 (France)
- Tumor Virology - Cancer Science 2026 (UAE)
- Types Of Cancers - Women Oncology-2026 (USA)
- Veterinary Oncology - Women Oncology-2026 (USA)
- Young Women and Breast Cancer - Breast Cancer-2026 (Italy)